Fate Therapeutics (FATE) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Fate Therapeutics (FATE) over the last 14 years, with Q3 2025 value amounting to -$1.5 billion.
- Fate Therapeutics' Retained Earnings fell 1159.82% to -$1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 billion, marking a year-over-year decrease of 1159.82%. This contributed to the annual value of -$1.4 billion for FY2024, which is 1537.16% down from last year.
- According to the latest figures from Q3 2025, Fate Therapeutics' Retained Earnings is -$1.5 billion, which was down 1159.82% from -$1.5 billion recorded in Q2 2025.
- In the past 5 years, Fate Therapeutics' Retained Earnings ranged from a high of -$602.0 million in Q1 2021 and a low of -$1.5 billion during Q3 2025
- For the 5-year period, Fate Therapeutics' Retained Earnings averaged around -$1.1 billion, with its median value being -$1.1 billion (2023).
- In the last 5 years, Fate Therapeutics' Retained Earnings plummeted by 4762.96% in 2021 and then tumbled by 1159.82% in 2025.
- Over the past 5 years, Fate Therapeutics' Retained Earnings (Quarter) stood at -$769.1 million in 2021, then tumbled by 36.63% to -$1.1 billion in 2022, then decreased by 15.31% to -$1.2 billion in 2023, then dropped by 15.37% to -$1.4 billion in 2024, then fell by 7.44% to -$1.5 billion in 2025.
- Its Retained Earnings was -$1.5 billion in Q3 2025, compared to -$1.5 billion in Q2 2025 and -$1.4 billion in Q1 2025.